ACI Formulations (DHA:ACIFORMULA) Valuation Rank

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DHA:ACIFORMULA ACI Formulations PLC DHA:ACIFORMULA
88 GF Score
Price BDT172.00
GF Value BDT149.48
Valuation Modestly Overvalued
! 8 Warning Signs
View Full Analysis

What is ACI Formulations Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

ACI Formulations Valuation Rank Related Terms

DHA:ACIFORMULA
88GF Score
ACI Formulations PLC DHA:ACIFORMULA
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is ACI Formulations (DHA:ACIFORMULA) Overvalued in 2026?

Based on GuruFocus' analysis, ACI Formulations stock appears to be overvalued. The current stock price of BDT172.00 is trading 15.1% above its estimated GF Value™ of BDT149.48. GuruFocus considers ACI Formulations to be Modestly Overvalued.

Key valuation signals for DHA:ACIFORMULA:

  • Valuation Rank:
  • GF Value™: BDT149.48 vs. price of BDT172.00 (15.1% above fair value)
  • GF Score™: 88/100 with 8 warning signs

No single metric tells the full story. See the DHA:ACIFORMULA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

ACI Formulations Business Description

Address ACI Centre, 245, Tejgaon Industrial Area, Dhaka, BGD, 1208
ACI Formulations PLC is engaged in the manufacturing and marketing of several agrochemical and consumer products. The company offers a complete range of cost-effective solutions for farmers through formulating and marketing insecticides, herbicides, fungicides, miticides, etc. Its businesses are Pharmaceuticals, Salt, Skincare & Antiseptics, Kitchen Care, Fabric Care, Surface Care, Herbal Care, Lavatory Care, and Others. The group's reportable segments are Crop Care and Public Health (CC & PH), which include manufacturing and selling crop care and public health products; Mosquito coil (M. Coil) includes manufacturing and selling mosquito coil products; Aerosol provides manufacturing and selling aerosol and air freshener products; and Paint covers manufacture and sell paint products.
88GF Score

Get the complete analysis for DHA:ACIFORMULA

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT172.00
Price
BDT149.48
GF Value